A4 Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 25-06-2024
- Paid Up Capital ₹ 1.10 M
as on 25-06-2024
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.20 M
as on 25-06-2024
- Revenue 66000.00%
(FY 2020)
- Profit 180.05%
(FY 2020)
- Ebitda -955.60%
(FY 2020)
- Net Worth 4.55%
(FY 2020)
- Total Assets 5.81%
(FY 2020)
About A4 Pharma
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.10 M.
The company currently has active open charges totaling ₹1.20 M.
Anil Kumar and Ayush Rishi serve as directors at the Company.
- CIN/LLPIN
U52100HR2015PTC057608
- Company No.
057608
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Dec 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Faridabad, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at A4 Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ayush Rishi  | Director | 06-Jun-2020 | Current |
| Anil Kumar | Director | 19-Dec-2015 | Current |
Financial Performance and Corporate Structure Insights of A4 Pharma.
A4 Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 66000% increase. The company also saw a substantial improvement in profitability, with a 180.05% increase in profit. The company's net worth moved up by a moderate rise of 4.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of A4 Pharma?
In 2020, A4 Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 31 Jan 2022 | ₹1.20 M | Open |
How Many Employees Work at A4 Pharma?
Unlock and access historical data on people associated with A4 Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of A4 Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped A4 Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
